The work carried out in this area involves collecting core descriptive data on :
- Drug legislation and practice
- National strategies/action plans on drugs
- Coordination arrangements in the field of drugs
- and public expenditure on drugs.
The European Legal Database on Drugs (ELDD) is the EMCDDA online archive of information on European drugs-related legislation and provides access to legislative texts currently in force in the EU Member States and Norway, which can be accessed through a search function. Country profiles provide an overview of drug legislation by country. Comparative studies and a special section on main trends in drug law give further information on the legal position of EU countries with regard to illicit drugs. News and registration services enable you to keep abreast of new developments. In preparation for their full integration into the work of the Centre, the candidate countries are now being added to the database as the information becomes available.
The EMCDDA's policy briefing Drug in focus No. 2 entitled 'Drug users and the law in the EU', offers policy-makers the latest findings on key issues in this field and is designed to inform the decision-making process in this domain.
No. 5 in the EMCDDA's Insights Series, is entitled 'Prosecution of drug users in Europe: varying pathways to similar objectives', and details research carried out in 2000 (with updates of laws to September 2001) on the actual implementation of the drug laws by the police, prosecution and courts in the EU countries. We offer the executive summary (53KB, PDF) - for purchase of the full publication, please consult the ordering details.
How international and national legislation on substitution treatment is enforced in the EU is the focus of a recent EMCDDA study carried out by the Catholic University of Leuven (Belgium). The study entitled 'Legal aspects of substitution treatment: an insight into nine EU countries' (1556 KB) looks at the impact of such legislation on the status, design and organisation of substitution treatment programmes and how they are accepted by the community as a whole. See also the sections in the Annual reports 2003 on legal developments in the EU and Norway and in the acceding and candidate countries.
National Drug Strategies seen as increasingly vital in tackling the drug phenomenon. The EMCDDA monitors developments and trends in this field. The study 'Strategies and coordination in the field of drugs in the European Union', undertaken in 2002 by the EMCDDA with the collaboration of the European Commission gives a first comprehensive overviews of action plans, strategy papers and coordination mechanisms in the EU countries in the field of drugs. In 2003 the EMCDDA produced a similar study on the candidate and acceding countries. Published in the 2003 EMCDDA Annual report, the research, done in collaboration with officials of central and eastern European countries, gives access to strategies mechanisms and trends in the domain. Click here for more detailed information on country profiles, summary tables and charts, and links to official documents. See also the sections in the Annual reports 2003 on national drug policy developments in the EU and Norway and in the acceding and candidate countries.
Over the past 15 years an international consensus has evolved around the concept of co-ordination in drugs policies: co-ordination is not only important, it represents the key element in any policy measure aiming to be comprehensive, balanced and effective. The study 'Strategies and coordination in the field of drugs in the European Union', gives already a comprehensive overview of models and characteristics of coordination in the EU member states. The EMCDDA's policy briefing Drugs in focus No. 9 entitled 'Coordination: a key element of national and European drug policy, goes further offering (in all EU languages), policy-makers the latest findings in this field and addressing decision-making with policy considerations on the issue. The EMCDDA constantly monitors the development and trends in this field, giving access to country profiles, synoptic tables and charts, models in use and links to related national sites. See also the sections in the Annual reports 2003 on national drug policy developments in the EU and Norway and in the acceding and candidate countries.
The EMCDDA is studying how the drugs budget is organised in different Member States. An initial overview (using the information available) of the first comprehensive research carried out at European level on public expenditure is available: Public spending on drugs in the European Union during the 1990s - retrospective research (2103KB). The executive summary (464KB) of this report is also available.
For more on drug related expenditure click here.
See also the section in the Annual report 2006 on public expenditure in the area of drug-demand reduction.